Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07117318) titled 'Rectal NSAIDs With/Without PD Stent for PEP Prevention' on Aug. 5.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Triple (Participant, Care Provider, Outcomes Assessor).
Primary Sponsor: Air Force Military Medical University, China
Condition:
Post-ERCP Acute Pancreatitis
Non-steroid Anti-inflammatory Drugs
Pancreatic Duct Stent Placement
Intervention:
Drug: NSAIDs
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: July 1, 2025
Target Sample Size: 1278
Countries of Recruitment:
China
To kno...